Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06657781 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis

Study acronym: PLAQSEPSIS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
: Sepsis, now defined as life-threatening organ dysfunction due to a dysregulated host response to infection, is an important global health problem representing about a fifth of all global deaths. It can be associated, in some cases, with multiple organ failure and cytokine storm. The main objective of this study is to estimate and to compare the activation rate of the Nucleotide-binding domain Leucine Rich repeat containing Protein 3 (NLRP3) inflammasome in platelets between five groups of patients suffering from bacterial and/or viral sepsis, with different severity levels according to Sequential Organ Failure Assessment (SOFA) score to precise the platelets' implication in this cytokine storm.
Trial Details
NCT Number NCT06657781
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions
(from sponsor)		 Bacterial Sepsis
Related terms Sepsis
Enrollment 171 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov